A new digital health platform designed to transform early detection and ongoing management of hormonal and reproductive conditions has earned international acclaim, winning the Best Research Innovation of the Year Award at the NextGen Innovation Challenge in London, United Kingdom.
Developed by Dr. Jide Ebenezer Taiwo Akinsola, a Senior Lecturer at Abiola Ajimobi Technical University, Ibadan, the platform—named Artificial Intelligence for Monitoring Hormonal Endocrine and Reproductive Health (AIMHER)—focuses on bridging critical gaps in people’s healthcare through continuous, data-driven monitoring.
Transforming Proactive Health Monitoring
AIMHER is engineered to give users comprehensive oversight of four interconnected pillars of well-being: mental, hormonal, metabolic, and reproductive health. Rather than relying solely on sporadic clinical visits, the platform uses advanced machine learning to continuously analyse user health vitals and menstrual signals.
A core breakthrough of the application is its ability to generate an accurate, personalized risk score for Polycystic Ovary Syndrome (PCOS)—a widespread yet frequently under-diagnosed condition affecting women of reproductive age. By flagging early indicators and tracking long-term physiological patterns, AIMHER equips women and healthcare providers with actionable insights to manage symptoms before severe metabolic or reproductive complications develop.

Rising Above 3,000 Innovators to Win in London
The technical depth and healthcare impact of AIMHER propelled Dr. Akinsola through a rigorous multi-stage competition organised by Nigeria’s National Board for Technology Incubation (NBTI) and the Federal Ministry of Innovation, Science and Technology, in partnership with UKALD, London.
National Screening (6 August 2026): AIMHER was selected among the top 70 innovations out of 3,000 entries screened nationwide in Nigeria.
International Pitch (9 October 2026): Traveling to the UK with full NBTI sponsorship and diplomatic support, Dr. Akinsola pitched AIMHER at the Grand Finale held at the Exhibition Centre, London (ExCeL), presenting before international investors, policymakers, and healthcare stakeholders.
Global Recognition: Standing out for its originality and potential impact on global healthcare ecosystems, AIMHER placed Dr. Akinsola among the top 18 finalists invited for one-on-one investor scaling pitches across four countries.
At the Executive Business Dinner following the finale, Dr. Akinsola was officially named a winner of the Best Research Innovation of the Year Award, presented by Dr. Olusola Odusanya, Director-General/CEO of the National Centre for Technology Management. He also received a separate Certificate of Award of Excellence, signed by NBTI Director-General/CEO Dr. Kazeem Kolawole Raji, recognizing his contribution to advancing Nigeria’s innovation ecosystem.
Looking Ahead: Global Rollout and Institutional Partnerships
With copyright and trademark protections already secured, AIMHER Health is preparing for an upcoming commercial launch in Nigeria and international markets. The rollout will offer direct subscriptions for individual users alongside strategic partnerships with healthcare institutions.
Beyond validating the platform’s scientific merit, the London win strengthens cross-border collaboration between Nigeria and the UK in medical technology incubation—giving AIMHER the institutional visibility and investor backing needed to bring accessible, AI-driven preventive care to women in Nigeria, across Africa, and around the world.




